CN106978425A - The albumen of the sugared 5 phosphoric acid reduction isomerase genes of the deoxidation D of Babesia orientalis 1 wood paulownias and its coding - Google Patents
The albumen of the sugared 5 phosphoric acid reduction isomerase genes of the deoxidation D of Babesia orientalis 1 wood paulownias and its coding Download PDFInfo
- Publication number
- CN106978425A CN106978425A CN201710086334.9A CN201710086334A CN106978425A CN 106978425 A CN106978425 A CN 106978425A CN 201710086334 A CN201710086334 A CN 201710086334A CN 106978425 A CN106978425 A CN 106978425A
- Authority
- CN
- China
- Prior art keywords
- orientalis
- babesia
- leu
- babesia orientalis
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000433931 Babesia orientalis Species 0.000 title claims abstract description 53
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title 2
- 108090000769 Isomerases Proteins 0.000 title 1
- 240000002834 Paulownia tomentosa Species 0.000 title 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 title 1
- 239000002023 wood Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 58
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 22
- 239000010452 phosphate Substances 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 24
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 24
- 239000000427 antigen Substances 0.000 abstract description 10
- 102000036639 antigens Human genes 0.000 abstract description 10
- 108091007433 antigens Proteins 0.000 abstract description 10
- 201000008680 babesiosis Diseases 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 17
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 230000003053 immunization Effects 0.000 description 14
- 238000002649 immunization Methods 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- 108700026244 Open Reading Frames Proteins 0.000 description 13
- 239000002299 complementary DNA Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000001962 electrophoresis Methods 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 108091092584 GDNA Proteins 0.000 description 7
- 239000002033 PVDF binder Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000004520 electroporation Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000003259 recombinant expression Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 241000223836 Babesia Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 2
- 241000224482 Apicomplexa Species 0.000 description 2
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 239000012722 SDS sample buffer Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 201000001505 hemoglobinuria Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- -1 isoprenoid compounds Chemical class 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 1
- BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 1
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 1
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 1
- GORKKVHIBWAQHM-GCJQMDKQSA-N Ala-Asn-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GORKKVHIBWAQHM-GCJQMDKQSA-N 0.000 description 1
- MVBWLRJESQOQTM-ACZMJKKPSA-N Ala-Gln-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O MVBWLRJESQOQTM-ACZMJKKPSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- IFKQPMZRDQZSHI-GHCJXIJMSA-N Ala-Ile-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O IFKQPMZRDQZSHI-GHCJXIJMSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- OTCJMMRQBVDQRK-DCAQKATOSA-N Arg-Asp-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OTCJMMRQBVDQRK-DCAQKATOSA-N 0.000 description 1
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 1
- YHQGEARSFILVHL-HJGDQZAQSA-N Arg-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)O YHQGEARSFILVHL-HJGDQZAQSA-N 0.000 description 1
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 1
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 1
- XMGVWQWEWWULNS-BPUTZDHNSA-N Arg-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N XMGVWQWEWWULNS-BPUTZDHNSA-N 0.000 description 1
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 1
- ZKDGORKGHPCZOV-DCAQKATOSA-N Asn-His-Arg Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZKDGORKGHPCZOV-DCAQKATOSA-N 0.000 description 1
- PTSDPWIHOYMRGR-UGYAYLCHSA-N Asn-Ile-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O PTSDPWIHOYMRGR-UGYAYLCHSA-N 0.000 description 1
- FVKHEKVYFTZWDX-GHCJXIJMSA-N Asn-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N FVKHEKVYFTZWDX-GHCJXIJMSA-N 0.000 description 1
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 1
- NJSNXIOKBHPFMB-GMOBBJLQSA-N Asn-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N)N NJSNXIOKBHPFMB-GMOBBJLQSA-N 0.000 description 1
- ANRZCQXIXGDXLR-CWRNSKLLSA-N Asn-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(=O)N)N)C(=O)O ANRZCQXIXGDXLR-CWRNSKLLSA-N 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- LDLZOAJRXXBVGF-GMOBBJLQSA-N Asp-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N LDLZOAJRXXBVGF-GMOBBJLQSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- BRRPVTUFESPTCP-ACZMJKKPSA-N Asp-Ser-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O BRRPVTUFESPTCP-ACZMJKKPSA-N 0.000 description 1
- UTLCRGFJFSZWAW-OLHMAJIHSA-N Asp-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O UTLCRGFJFSZWAW-OLHMAJIHSA-N 0.000 description 1
- 101100008050 Caenorhabditis elegans cut-6 gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- KABHAOSDMIYXTR-GUBZILKMSA-N Cys-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N KABHAOSDMIYXTR-GUBZILKMSA-N 0.000 description 1
- UPURLDIGQGTUPJ-ZKWXMUAHSA-N Cys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N UPURLDIGQGTUPJ-ZKWXMUAHSA-N 0.000 description 1
- VFGADOJXRLWTBU-JBDRJPRFSA-N Cys-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N VFGADOJXRLWTBU-JBDRJPRFSA-N 0.000 description 1
- XZKJEOMFLDVXJG-KATARQTJSA-N Cys-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)N)O XZKJEOMFLDVXJG-KATARQTJSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 1
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 1
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 1
- OXEMJGCAJFFREE-FXQIFTODSA-N Glu-Gln-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O OXEMJGCAJFFREE-FXQIFTODSA-N 0.000 description 1
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 1
- SWDNPSMMEWRNOH-HJGDQZAQSA-N Glu-Pro-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWDNPSMMEWRNOH-HJGDQZAQSA-N 0.000 description 1
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 1
- FGGKGJHCVMYGCD-UKJIMTQDSA-N Glu-Val-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGGKGJHCVMYGCD-UKJIMTQDSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- KFMBRBPXHVMDFN-UWVGGRQHSA-N Gly-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCNC(N)=N KFMBRBPXHVMDFN-UWVGGRQHSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- PCPOYRCAHPJXII-UWVGGRQHSA-N Gly-Lys-Met Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PCPOYRCAHPJXII-UWVGGRQHSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- MAABHGXCIBEYQR-XVYDVKMFSA-N His-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MAABHGXCIBEYQR-XVYDVKMFSA-N 0.000 description 1
- MPXGJGBXCRQQJE-MXAVVETBSA-N His-Ile-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O MPXGJGBXCRQQJE-MXAVVETBSA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- HLYBGMZJVDHJEO-CYDGBPFRSA-N Ile-Arg-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HLYBGMZJVDHJEO-CYDGBPFRSA-N 0.000 description 1
- QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 1
- RPZFUIQVAPZLRH-GHCJXIJMSA-N Ile-Asp-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O)N RPZFUIQVAPZLRH-GHCJXIJMSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 1
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 1
- GNXGAVNTVNOCLL-SIUGBPQLSA-N Ile-Tyr-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N GNXGAVNTVNOCLL-SIUGBPQLSA-N 0.000 description 1
- JCGMFFQQHJQASB-PYJNHQTQSA-N Ile-Val-His Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O JCGMFFQQHJQASB-PYJNHQTQSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 1
- NTRAGDHVSGKUSF-AVGNSLFASA-N Leu-Arg-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NTRAGDHVSGKUSF-AVGNSLFASA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 1
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- CRNNMTHBMRFQNG-GUBZILKMSA-N Lys-Glu-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N CRNNMTHBMRFQNG-GUBZILKMSA-N 0.000 description 1
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 1
- GNLJXWBNLAIPEP-MELADBBJSA-N Lys-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCCN)N)C(=O)O GNLJXWBNLAIPEP-MELADBBJSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- JQSIGLHQNSZZRL-KKUMJFAQSA-N Lys-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N JQSIGLHQNSZZRL-KKUMJFAQSA-N 0.000 description 1
- ZUGVARDEGWMMLK-SRVKXCTJSA-N Lys-Ser-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN ZUGVARDEGWMMLK-SRVKXCTJSA-N 0.000 description 1
- SQXZLVXQXWILKW-KKUMJFAQSA-N Lys-Ser-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQXZLVXQXWILKW-KKUMJFAQSA-N 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 1
- LCPUWQLULVXROY-RHYQMDGZSA-N Met-Lys-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LCPUWQLULVXROY-RHYQMDGZSA-N 0.000 description 1
- VAGCEUUEMMXFEX-GUBZILKMSA-N Met-Met-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O VAGCEUUEMMXFEX-GUBZILKMSA-N 0.000 description 1
- SGWDZVVIRDOXSG-BPUTZDHNSA-N Met-Trp-Cys Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CS)C(O)=O)=CNC2=C1 SGWDZVVIRDOXSG-BPUTZDHNSA-N 0.000 description 1
- CQRGINSEMFBACV-WPRPVWTQSA-N Met-Val-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O CQRGINSEMFBACV-WPRPVWTQSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010066427 N-valyltryptophan Proteins 0.000 description 1
- 108010065395 Neuropep-1 Proteins 0.000 description 1
- LSXGADJXBDFXQU-DLOVCJGASA-N Phe-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 LSXGADJXBDFXQU-DLOVCJGASA-N 0.000 description 1
- CTNODEMQIKCZGQ-JYJNAYRXSA-N Phe-Gln-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 CTNODEMQIKCZGQ-JYJNAYRXSA-N 0.000 description 1
- GPSMLZQVIIYLDK-ULQDDVLXSA-N Phe-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O GPSMLZQVIIYLDK-ULQDDVLXSA-N 0.000 description 1
- SHUFSZDAIPLZLF-BEAPCOKYSA-N Phe-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O SHUFSZDAIPLZLF-BEAPCOKYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- NOXSEHJOXCWRHK-DCAQKATOSA-N Pro-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 NOXSEHJOXCWRHK-DCAQKATOSA-N 0.000 description 1
- IBGCFJDLCYTKPW-NAKRPEOUSA-N Pro-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 IBGCFJDLCYTKPW-NAKRPEOUSA-N 0.000 description 1
- LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 1
- KNCJWSPMTFFJII-ZLUOBGJFSA-N Ser-Cys-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KNCJWSPMTFFJII-ZLUOBGJFSA-N 0.000 description 1
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 1
- VXYQOFXBIXKPCX-BQBZGAKWSA-N Ser-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N VXYQOFXBIXKPCX-BQBZGAKWSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- BCAVNDNYOGTQMQ-AAEUAGOBSA-N Ser-Trp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(O)=O BCAVNDNYOGTQMQ-AAEUAGOBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 1
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 1
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 1
- VUXIQSUQQYNLJP-XAVMHZPKSA-N Thr-Ser-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N)O VUXIQSUQQYNLJP-XAVMHZPKSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 1
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 1
- UNUZEBFXGWVAOP-DZKIICNBSA-N Tyr-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UNUZEBFXGWVAOP-DZKIICNBSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- XGZBEGGGAUQBMB-KJEVXHAQSA-N Tyr-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N)O XGZBEGGGAUQBMB-KJEVXHAQSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 1
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 1
- WDIWOIRFNMLNKO-ULQDDVLXSA-N Val-Leu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WDIWOIRFNMLNKO-ULQDDVLXSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- OJOMXGVLFKYDKP-QXEWZRGKSA-N Val-Met-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OJOMXGVLFKYDKP-QXEWZRGKSA-N 0.000 description 1
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 1
- LGXUZJIQCGXKGZ-QXEWZRGKSA-N Val-Pro-Asn Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N LGXUZJIQCGXKGZ-QXEWZRGKSA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 108010054812 diprotin A Proteins 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 1
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 108010088381 isoleucyl-lysyl-valyl-alanyl-valine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000601 reactogenic effect Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01267—1-Deoxy-D-xylulose-5-phosphate reductoisomerase (1.1.1.267)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了东方巴贝斯虫1‑脱氧‑D‑木桐糖‑5‑磷酸还原异构酶基因,该基因具有如SEQ ID NO:1所示的核苷酸序列,本发明还公开了所述基因所编码的蛋白,该蛋白具有如序列表SEQ ID NO:2所示的氨基酸序列。本发明公开的重组蛋白可有效检测感染水牛血液中的东方巴贝斯虫病抗原的存在,具有良好的反应原性,有助于控制水牛的巴贝斯虫病在我国的流行和传播。
The present invention discloses a Babesia orientalis 1-deoxy-D-xylose-5-phosphate reductoisomerase gene, which has a nucleotide sequence as shown in SEQ ID NO: 1. The present invention also discloses the gene The protein encoded by the gene has the amino acid sequence shown in SEQ ID NO: 2 in the sequence listing. The recombinant protein disclosed by the invention can effectively detect the presence of the babesiosis orientalis antigen in the blood of infected buffaloes, has good reactogenicity, and is helpful for controlling the prevalence and spread of the babesiasiasis in buffaloes in my country.
Description
技术领域technical field
本发明属于分子生物学领域,涉及一个新基因及其重组蛋白,具体是指东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶(BoDXR)基因及其编码的重组蛋白,本发明还涉及重组蛋白的应用。The invention belongs to the field of molecular biology and relates to a new gene and its recombinant protein, specifically referring to the recombination of the Babesia orientalis 1-deoxy-D-xylose-5-phosphate reductoisomerase (BoDXR) gene and its encoding Protein, the present invention also relates to the application of recombinant protein.
背景技术Background technique
巴贝斯虫病又称梨形虫病、蜱热或德克萨斯热等,是由巴贝斯属的多种蜱传性,红细胞内寄生的原虫引起的。临床上主要引起多种脊椎动物的发热、血红蛋白尿、溶血性贫血和死亡。该病原属于顶复门,梨形虫纲,巴贝斯科,巴贝斯属的巴贝斯虫,最早于1888年,Victor Babes在患有血红蛋白尿和红色水热症状的牛红细胞内发现的该类微生物。Babesiosis, also known as pear body disease, tick fever or Texas fever, is caused by a variety of tick-borne, intraerythrocytic protozoa of the genus Babesia. Clinically, it mainly causes fever, hemoglobinuria, hemolytic anemia and death in various vertebrates. The pathogen belongs to Apicomplexa, Piroplasma, Babesco, Babesia of the genus Babesia, which was first discovered in 1888 by Victor Babes in bovine erythrocytes suffering from hemoglobinuria and red water fever symptoms .
目前,全世界大约有一半的养牛产业受到巴贝斯虫的威胁,给热带和亚热带国家的畜牧业造成了严重的经济损失。根据目前研究报告在我国南方的湖北、福建、江西、安徽、浙江、湖南、广西、云南、贵州等省份,引起水牛发病的主要是东方巴贝斯虫。该寄生虫具有严格地宿主特异性,仅感染水牛。它的传播媒介(镰形扇头蜱)是一种三宿主蜱,一年发生一代,可经卵传播东方巴贝斯虫。东方巴贝斯虫病主要在夏秋季节爆发,给畜牧业造成重大地经济损失。Currently, about half of the world's cattle industry is threatened by Babesia, causing serious economic losses to the livestock industry in tropical and subtropical countries. According to current research reports, in Hubei, Fujian, Jiangxi, Anhui, Zhejiang, Hunan, Guangxi, Yunnan, Guizhou and other provinces in southern my country, the main cause of buffalo disease is Babesia orientalis. The parasite is strictly host specific, infecting only buffalo. Its vector (Rhizocephalus falciparum) is a three-host tick with one generation per year that transmits Babesia orientalis via eggs. Babesia orientalis mainly breaks out in summer and autumn, causing significant economic losses to animal husbandry.
综合以上可看出,一旦某区域成为疫区,东方巴贝斯虫病便难以根治和清除,因此要控制该病的传播和流行,诊断和疫苗尤为重要。到目前为止,东方巴贝斯虫病的检测没有诊断试剂盒。因而筛选、鉴定具有良好免疫原性和反应原性的东方巴贝斯虫抗原便是解决途径之一。Based on the above, it can be seen that once a certain area becomes an epidemic area, it is difficult to cure and eliminate Babesia orientalis disease. Therefore, to control the spread and prevalence of the disease, diagnosis and vaccine are particularly important. To date, there are no diagnostic kits for the detection of babesiosis orientalis. Therefore, screening and identification of Babesia orientalis antigens with good immunogenicity and reactogenicity is one of the solutions.
已知哺乳动物合成生命所需的类异戊二烯化合物采用的是甲羟戊酸途径,而东方巴贝斯虫合成类异戊二烯生物采用的是非甲羟戊酸途径,与哺乳动物的合成途径不一样,因而在东方巴贝斯虫体内克隆出1-脱氧-D-木桐糖-5-磷酸还原异构酶基因,构建原核表达载体,制备出多克隆抗体,筛选、鉴定出具有良好免疫原性和反应原性的东方巴贝斯虫抗原,对运用于临床检测东方巴贝斯虫病的感染情况具有重要的意义。It is known that mammals use the mevalonate pathway to synthesize the isoprenoid compounds required for life, while Babesia orientalis uses the non-mevalonate pathway to synthesize isoprenoids, which is similar to the synthesis of mammals The pathways are different, so the 1-deoxy-D-xoutonose-5-phosphate reductoisomerase gene was cloned in Babesia orientalis, the prokaryotic expression vector was constructed, polyclonal antibodies were prepared, and the antibodies with good immunity were screened and identified. The antigenic and reactogenic Babesia orientalis antigens are of great significance for the clinical detection of Babesia orientalis infection.
发明内容Contents of the invention
本发明的第一个目的是从东方巴贝斯虫中获得1-脱氧-D-木桐酸-5磷酸还原异构酶基因。The first object of the present invention is to obtain the 1-deoxy-D-liponate-5-phosphate reductoisomerase gene from Babesia orientalis.
本发明的第二个目的是将所述东方巴贝斯虫1-脱氧-D-木桐酸-5磷酸还原异构酶基因在大肠杆菌表达系统中高效表达获得重组蛋白。The second object of the present invention is to efficiently express the Babesia orientalis 1-deoxy-D-woodoic acid-5-phosphate reductoisomerase gene in an Escherichia coli expression system to obtain a recombinant protein.
本发明的第三个目的是提供上述重组蛋白在制备东方巴贝斯虫病检测试剂盒中的用途。The third object of the present invention is to provide the use of the above-mentioned recombinant protein in the preparation of a detection kit for Babesia orientalis.
为实现上述目的,本发明采用了以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
(1)东方巴贝斯虫1-脱氧-D-木桐酸-5磷酸还原异构酶基因的获得:利用聚合酶链式反应(PCR)的方法,分别以东方巴贝斯虫全基因组和总RNA反转录成的cDNA为模板,经PCR得到1-脱氧-D-木桐酸-5磷酸还原异构酶目的片段,其全基因核苷酸序列的开放阅读框(ORF)如序列表SEQ ID NO:1所示。(1) Acquisition of Babesia orientalis 1-deoxy-D-woodoic acid-5 phosphate reductoisomerase gene: using the polymerase chain reaction (PCR) method, the whole genome and total RNA of Babesia orientalis The reverse-transcribed cDNA is used as a template, and the target fragment of 1-deoxy-D-woodoic acid-5-phosphate reductoisomerase is obtained by PCR, and the open reading frame (ORF) of the whole gene nucleotide sequence is as shown in the sequence table SEQ ID NO: 1 shown.
(2)编码了所述1-脱氧-D-木桐酸-5磷酸还原异构酶基因的重组蛋白,其氨基酸序列如序列表SEQ ID NO:2所示。(2) A recombinant protein encoding the 1-deoxy-D-woodoic acid-5-phosphate reductoisomerase gene, the amino acid sequence of which is shown in SEQ ID NO: 2 in the sequence table.
(3)所述重组蛋白的制备方法为:将序列表SEQ ID NO:1所示的东方巴贝斯虫1-脱氧-D-木桐酸-5磷酸还原异构酶开放阅读框(ORF)与大肠杆菌表达载体构建重组表达质粒pE32a-BoDXR,电转化至BL21(DE3)中,抗生素氨苄青霉素筛选高抗性的转化子,并用0.2mmol/L IPTG于37℃诱导4h。收集上述IPTG诱导表达的菌液,对其进行分离纯化的蛋白即为编码了1-脱氧-D-木桐酸-5磷酸还原异构酶基因的重组蛋白。(3) The preparation method of the recombinant protein is as follows: the open reading frame (ORF) of Babesia orientalis 1-deoxy-D-woodoic acid-5 phosphate reductoisomerase shown in the sequence table SEQ ID NO: 1 and Escherichia coli expression vector constructed recombinant expression plasmid pE32a-BoDXR, electrotransformed into BL21(DE3), antibiotic ampicillin selected highly resistant transformants, and induced with 0.2mmol/L IPTG at 37°C for 4h. The above-mentioned IPTG-induced expression bacterial liquid is collected, and the protein isolated and purified is the recombinant protein encoding the 1-deoxy-D-woodoic acid-5-phosphate reductoisomerase gene.
(4)重组蛋白纯化处理:按上述方法诱导表达1000ml菌液,将表达的菌液转移到离心管于4℃条件下8000r/min离心10min集菌。取30mL buffer A(PH7.8)(Tris.base50mMEDTA 0.5mM NaCl 50mM甘油5%DTT 5mM)重悬菌体沉淀后,使用压力破碎仪破碎3次;4℃,10000r/min离心5min,弃上清,收集沉淀,用PBS洗涤三次后,用包涵体纯化的方法提取蛋白。(4) Recombinant protein purification treatment: Induce expression in 1000ml of bacterial solution according to the above method, transfer the expressed bacterial solution to a centrifuge tube and centrifuge at 8000r/min for 10min at 4°C to collect the bacteria. Take 30mL buffer A (PH7.8) (Tris.base 50mM EDTA 0.5mM NaCl 50mM glycerol 5% DTT 5mM) to resuspend the bacteria and precipitate, then use a pressure breaker to crush 3 times; 4°C, 10000r/min centrifuge 5min, discard the supernatant , the precipitate was collected, washed three times with PBS, and the protein was extracted by inclusion body purification.
(5)多克隆抗体的制备:为制备BoDXR重组蛋白的抗血清,以纯化好的重组蛋白免疫5只4周龄的健康SPF昆明小鼠,免疫之前断尾采取血液0.5mL作为阴性对照,首次免疫将纯化好的100ug重组蛋白与完全弗氏佐剂乳化后,皮下注射,每只小鼠注剂量为200uL,在首次免疫后第14,21,28天分别以50ug纯化蛋白与不完全弗氏佐剂乳化后皮下多点注射加强免疫,在最后一次免疫后第7天采集抗血清。(5) Preparation of polyclonal antibody: In order to prepare the antiserum of BoDXR recombinant protein, five 4-week-old healthy SPF Kunming mice were immunized with the purified recombinant protein. After the immunization, the purified 100ug recombinant protein was emulsified with complete Freund's adjuvant, and injected subcutaneously. After the adjuvant was emulsified, multi-point subcutaneous injection was used to boost the immunization, and the antiserum was collected 7 days after the last immunization.
(6)本发明获得的重组蛋白具有生物活性,具有良好的反应原性。以制备的多克隆抗体为一抗,然后分别以东方巴贝斯的全虫抗原虫和健康的水牛红细胞反应为抗原,HRP标记的羊抗鼠IgG为二抗进行Western blot分析,检测重组表达蛋白的反应原性,结果显示仅东方巴贝斯虫全虫抗原有特异性的反应带,健康水牛红细胞无反应,所以制备的重组蛋白可用来有效地检测东方巴贝斯虫病。(6) The recombinant protein obtained by the present invention has biological activity and good reactogenicity. The prepared polyclonal antibody was used as the primary antibody, and then the antiprotozoa of Babes orientalis and healthy buffalo erythrocytes were used as the antigen, and the HRP-labeled goat anti-mouse IgG was used as the secondary antibody for Western blot analysis to detect the expression of the recombinant protein. Reactogenicity, the results show that only Babesia orientalis antigen has a specific reaction band, and healthy buffalo red blood cells have no reaction, so the prepared recombinant protein can be used to effectively detect Babesia orientalis.
本发明的有益效果:Beneficial effects of the present invention:
本发明涉及的编码的东方巴贝斯虫1-脱氧-D-木桐酸-5磷酸还原异构酶的重组蛋白可有效检测感染水牛血液中的东方巴贝斯虫病抗原的存在,具有良好的反应原性,有助于控制水牛的巴贝斯虫病在我国的流行和传播。The recombinant protein of Babesia orientalis 1-deoxy-D-woodoic acid-5 phosphate reductoisomerase encoded by the present invention can effectively detect the presence of Babesia orientalis antigen in the blood of infected buffaloes, and has a good response It can help to control the prevalence and spread of buffalo babesiosis in my country.
附图说明Description of drawings
图1为东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶基因扩增电泳图。1:从东方巴贝斯虫gDNA中扩增到目的基因;2:从东方巴贝斯虫cDNA中扩增到目的基因;3:阴性对照M:DNA分子量标准。Fig. 1 is the electrophoresis diagram of the amplification of the 1-deoxy-D-xytoside-5-phosphate reductoisomerase gene of Babesia orientalis. 1: Target gene amplified from Babesia orientalis gDNA; 2: Target gene amplified from Babesia orientalis cDNA; 3: Negative control M: DNA molecular weight standard.
图2为发明重组质粒的PCR扩增电泳图。所用引物是载体上的通用上游引物T7和目的基因的下游引物BoDXR-R2,1、2为挑取的两个阳性克隆子扩增后的目的片段;M:DNA分子量标准。Fig. 2 is the electrophoresis diagram of PCR amplification of the recombinant plasmid of the invention. The primers used are the universal upstream primer T7 on the carrier and the downstream primer BoDXR-R2 of the target gene, 1 and 2 are the target fragments amplified by the two picked positive clones; M: DNA molecular weight standard.
图3为本发明重组质粒双酶切产物电泳图。1、2均为使用BsaI XhoI(购自NEB生物公司)表达引物扩增产物酶切后的目的片段;M:DNA分子量标准。Fig. 3 is the electrophoresis diagram of the product of double enzyme digestion of the recombinant plasmid of the present invention. 1 and 2 are target fragments digested with expression primers amplified using BsaI XhoI (purchased from NEB Biological Company); M: DNA molecular weight standard.
图4为东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶的重组表达产物定性分析的SDS-PAGE电泳结果。1、3:未IPTG诱导的pET32a-BoDXR表达产物;2、4:诱导的pET32a-BoDXR;M:蛋白质分子质量标准。Fig. 4 is the SDS-PAGE electrophoresis result of the qualitative analysis of the recombinant expression product of Babesia orientalis 1-deoxy-D-xoutonose-5-phosphate reductoisomerase. 1, 3: pET32a-BoDXR expression product not induced by IPTG; 2, 4: induced pET32a-BoDXR; M: protein molecular mass standard.
图5为东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶的重组表达产物的SDS-PAGE电泳结果,图5A为可溶性分析SDS-PAGE电泳结果,图5B为纯化产物的SDS-PAGE电泳结果。1:未经IPTG诱导的pET32a-BoDXR表达产物;2:经IPTG诱导的pET32a-BoDXR表达产物;3:表达菌裂解液的上清;4:表达菌裂解液的包涵体;5:纯化后的重组表达产物;M:蛋白质分子质量标准。Figure 5 is the SDS-PAGE electrophoresis result of the recombinant expression product of Babesia orientalis 1-deoxy-D-xoutonia-5-phosphate reductoisomerase, Figure 5A is the result of SDS-PAGE electrophoresis for soluble analysis, and Figure 5B is the result of purification SDS-PAGE electrophoresis results of the product. 1: pET32a-BoDXR expression product not induced by IPTG; 2: pET32a-BoDXR expression product induced by IPTG; 3: supernatant of lysate of expressing bacteria; 4: inclusion body of lysate of expressing bacteria; 5: purified Recombinant expression product; M: protein molecular mass standard.
图6为东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶重组蛋白的Westernblot鉴定。6A鉴定BoDXR的正确表达;6B鉴定制备的多克隆抗体的质量;6C和6D鉴定体内和体外的BoDXR蛋白表达形式是一样的;1:BoDXR未经IPTG诱导;2:纯化后的r BoDXR蛋白;3:B.orientalis裂解物;4:水牛健康红细胞。Fig. 6 is the Western blot identification of the recombinant protein of Babesia orientalis 1-deoxy-D-xoutonose-5-phosphate reductoisomerase. 6A identifies the correct expression of BoDXR; 6B identifies the quality of the prepared polyclonal antibody; 6C and 6D identify the expression of BoDXR protein in vivo and in vitro is the same; 1: BoDXR is not induced by IPTG; 2: purified rBoDXR protein; 3: B. orientalis lysate; 4: Buffalo healthy red blood cells.
具体实施方式detailed description
下面结合实施例对本发明进行详细说明。The present invention will be described in detail below in conjunction with examples.
实施例1东方巴贝斯虫1-脱氧-D-木桐酸-5磷酸还原异构酶基因的克隆Example 1 Cloning of Babesia orientalis 1-deoxy-D-woodoic acid-5-phosphate reductoisomerase gene
1:东方巴贝斯虫的纯化及全虫抗原的提取1: Purification of Babesia orientalis and extraction of whole insect antigen
东方巴贝斯虫的纯化:将新鲜收集的染虫红细胞(染虫率约5~10%)装入一灭菌的含EDTAk抗凝剂的无RNase的离心管中,细胞间转移到15mL离心管中,3000rpm离心6min,去除上清与表面的白色絮状物(白细胞);加入血细胞3倍体积的1xPBS,混匀,3000rpm离心6min,去除上清,重复此操作2次直至上清为无色透明;然后加入5倍体积的红细胞裂解液,混匀,室温静置5min,12000rpm离心5min,去上清,收集沉淀。向沉淀中加入3倍体积的1xPBS,混匀后,用5mL注射器反复吹打10次,然后用灭过菌的2um的滤器过滤溶液,过滤后,12000rpm离心5min,收集沉淀,重复此步骤直至上清无色透明;沉淀用灭菌的无RNase的PBS洗一次,加入1/10体积的灭菌无RNase的PBS溶液,此即为纯化的无白细胞的东方巴贝斯虫体。Purification of Babesia orientalis: put freshly collected infected erythrocytes (infection rate is about 5-10%) into a sterilized RNase-free centrifuge tube containing EDTAk anticoagulant, and transfer the cells to a 15mL centrifuge tube In the middle, centrifuge at 3000rpm for 6min to remove the supernatant and white flocs (leukocytes) on the surface; add 1xPBS with 3 times the volume of blood cells, mix well, centrifuge at 3000rpm for 6min, remove the supernatant, repeat this operation twice until the supernatant is colorless Transparent; then add 5 times the volume of erythrocyte lysate, mix well, let stand at room temperature for 5 minutes, centrifuge at 12,000 rpm for 5 minutes, remove the supernatant, and collect the precipitate. Add 3 times the volume of 1xPBS to the precipitate, mix well, blow repeatedly with a 5mL syringe 10 times, then filter the solution with a sterilized 2um filter, after filtration, centrifuge at 12000rpm for 5min, collect the precipitate, repeat this step until the supernatant Colorless and transparent; the precipitate was washed once with sterilized RNase-free PBS, and 1/10 volume of sterilized RNase-free PBS solution was added, and this was the purified leukocyte-free Babesia orientalis body.
全虫抗原的提取:向上步获得了虫体中加入1/10体积的RAPI细胞裂解液,然后超声破碎30min后,12000rpm离心20min,上清即为得到的全虫抗原。Extraction of holozoan antigens: Add 1/10 volume of RAPI cell lysate to the parasites obtained in the upward step, and then ultrasonically disrupt for 30 minutes, then centrifuge at 12000 rpm for 20 minutes, and the supernatant is the obtained holozoan antigens.
2:东方巴贝斯虫全基因组的提取2: Extraction of the whole genome of Babesia orientalis
取200μL加了新鲜采集的含抗凝剂的东方巴贝斯血液置于1.5mL聚丙烯离心管中,按照天根血液基因组DNA提取试剂盒说明书进行提取,提取的全基因组保存于-20度。3:东方巴贝斯虫总RNA的提取Take 200 μL of freshly collected Orient Babes blood containing anticoagulant and place it in a 1.5 mL polypropylene centrifuge tube, and extract it according to the instructions of Tiangen Blood Genomic DNA Extraction Kit, and store the extracted whole genome at -20 degrees. 3: Extraction of total RNA from Babesia orientalis
所有提取RNA用的器皿均用0.1%DEPC水处理,150℃烘烤3h;塑料器皿经0.1%DEPC水浸泡过夜,121℃高温高压灭菌30min;金属用具经1mol/L的NaOH浸泡2h,经0.01%的DEPC水彻底冲洗后,37℃烘干;各试剂用无核糖核酸酶(Ribonuclease,RNase)的0.01%DEPC水配置。取400μL东方巴贝斯虫全血提取RNA。总RNA抽提按Trizol试剂的说明书进行。提取的总RNA样品冻存于-80℃,备用。All utensils used for RNA extraction were treated with 0.1% DEPC water and baked at 150°C for 3 hours; plastic utensils were soaked in 0.1% DEPC water overnight and sterilized at 121°C for 30 minutes; metal utensils were soaked in 1mol/L NaOH for 2h, After thoroughly rinsing with 0.01% DEPC water, dry at 37°C; each reagent was prepared with 0.01% DEPC water without ribonuclease (RNase). RNA was extracted from 400 μL whole blood of Babesia orientalis. Total RNA was extracted according to the instructions of Trizol reagent. Extracted total RNA samples were frozen at -80°C for future use.
4:东方巴贝斯虫总cDNA的合成4: Synthesis of total cDNA of Babesia orientalis
使用北京全式金公司的反转录试剂盒,以提取的东方巴贝斯虫总RNA为模板进行反转录,具体操作步骤为:Using the reverse transcription kit of Beijing Quanshijin Company, the total RNA of Babesia orientalis extracted was used as a template for reverse transcription. The specific operation steps are as follows:
①第一条链cDNA合成和gDNA去除①First-strand cDNA synthesis and gDNA removal
Anchored Oligo(dT)18引物0.5ug/uL) 1ulAnchored Oligo (dT) 18 Primer 0.5ug/uL) 1ul
总RNA 4ulTotal RNA 4ul
无RNA酶的水dH2O 3ulRNase-free water dH2O 3ul
混匀后,在PCR仪上进行下列条件的变性、退火反应:After mixing, perform denaturation and annealing reactions under the following conditions on a PCR instrument:
65℃5min冰上冰浴2min65°C for 5 minutes, ice bath on ice for 2 minutes
②在上述Microtube管中配制下列反转录反应液。② Prepare the following reverse transcription reaction solution in the above-mentioned Microtube tube.
2xES Reaction Mix 10ul2xES Reaction Mix 10ul
EasyScriptRT/RI Enzyme Mix 1uLEasyScript RT/RI Enzyme Mix 1uL
gDNA Remover 1uLgDNA Remover 1uL
③混匀后,在PCR仪上按下列条件进行反转录反应:③After mixing, carry out the reverse transcription reaction on the PCR instrument according to the following conditions:
42℃ 30min42℃ 30min
↓ ↓
85℃ 5min85℃ 5min
↓ ↓
处理后,冰上放置。After processing, keep on ice.
反转录所得的cDNA放-20保存备用。The cDNA obtained by reverse transcription was stored at -20°C for future use.
5:东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶的克隆及序列分析5: Cloning and Sequence Analysis of Babesia orientalis 1-deoxy-D-xyloose-5-phosphate reductoisomerase
1)引物设计1) Primer design
据NCBI/GenBank上已提交的已知顶复门寄生虫的1-脱氧-D-木桐糖-5-磷酸还原异构酶(DXR)序列信息,根据1-脱氧-D-木桐糖-5-磷酸还原异构酶序列的保守性,运用BLASTp的方法,在东方巴贝虫基因组数据库中用得到同源性最高的一段序列,然后用clonemanager软件分别在cDNA序列开放阅读框(ORF)的上下游区域,设计对引物(BoDXR-F1,BoDXR-R1);According to the 1-deoxy-D-xylose-5-phosphate reductoisomerase (DXR) sequence information of known apicomplexan parasites submitted on NCBI/GenBank, according to the 1-deoxy-D-xylose- For the conservation of the 5-phosphate reductoisomerase sequence, use the BLASTp method to obtain a sequence with the highest homology in the Babesia orientalis genome database, and then use clonemanager software to separate the cDNA sequence open reading frame (ORF) For the upstream and downstream regions, design a pair of primers (BoDXR-F1, BoDXR-R1);
BoDXR-F1:5’-ATGAATGCAGCAGTGAGTTTTTATG-3’BoDXR-F1:5'-ATGAATGCAGCAGTGAGTTTTTTATG-3'
BoDXR-R1:5’-TTAGTATGTGAAGCATTAATATATGTGATAG-3’。BoDXR-R1: 5'-TTAGTATGTGAAGCATTAATATATGTGATAG-3'.
2)PCR扩增:分别以东方巴贝斯虫gDNA和cDNA为模板进行PCR扩增,反应体系为25μL,PCR反应体系如下:2) PCR amplification: PCR amplification was performed using Babesia orientalis gDNA and cDNA as templates respectively, the reaction system was 25 μL, and the PCR reaction system was as follows:
PCR反应条件:反应条件为94℃5min;94℃30sec,55℃30sec,68℃1min 50sec;68℃10min;34个循环周期。PCR reaction conditions: the reaction conditions are 94°C for 5min; 94°C for 30sec, 55°C for 30sec, 68°C for 1min and 50sec; 68°C for 10min; 34 cycles.
3)PCR产物鉴定:扩增完成后,取PCR产物8μ加上2uL的6×核酸上样缓冲液点样,0.8%琼脂糖凝胶,1×TAE缓冲液,120V,电泳20分钟观察结果,结果显示用gDNA扩增得到的目的带和用cDNA扩增得到的目的带不一样,说明该基因含有内含子(见图1)。3) PCR product identification: After the amplification is completed, take 8μ of the PCR product plus 2uL of 6×nucleic acid loading buffer for spotting, 0.8% agarose gel, 1×TAE buffer, 120V, electrophoresis for 20 minutes to observe the results, The results showed that the target band amplified with gDNA was different from the target band amplified with cDNA, indicating that the gene contained introns (see Figure 1).
4)按照北京全式金DNA琼脂糖凝胶回收试剂盒的说明书,分别对扩增到的gDNA和cDNA进行切胶回收。4) According to the instructions of the Beijing Quanjin DNA Agarose Gel Recovery Kit, the amplified gDNA and cDNA were cut and recovered by gel cutting.
5)目的基因的克隆、筛选与测序5) Cloning, screening and sequencing of the target gene
取pEASY-Blunt载体1μL(50ng/uL)与胶回收的目的片段4μL混合于PCR管中,于PCR仪器中25度反应20min,取5μL连接产物,无菌条件下加入到50uL大肠杆菌Trans1-T1感受态细胞中,用移液器温和吹打混匀,冰浴放置30min,42℃水浴,热激90s,之后立即冰浴2min使之冷却,注意不要晃动。然后向感受态中加入500μL预热至37℃的LB培养液,180rpm 37℃温和振荡45min,使细菌恢复抗药性。恢复抗药性后,5000rpm离心3min,超净台弃部分上清,留100uL上清重悬沉淀,取80uL重悬液向含氨苄青霉素(AMP)(100μg/mL)的LB琼脂平板上均匀涂布,37℃正置半小时后,倒置平皿继续于37度培养10h,待肉眼看到单个白色菌落可挑菌。挑取两个菌落接种于含100μg/mL AMP的LB培养液中,剧烈振摇(180rpm)10~12h后,用载体上的通用引物扩增目的基因,PCR鉴定为阳性的克隆,取菌液送北京奥科鼎盛生物科技有限公司进行测序分析,结果显示用gDNA扩增得到的片段长度为1554bp用cDNA扩增得到片段长度为1371bp,cDNA扩增到的目的基因经分析,有完整的开放阅读框(ORF),其开放阅读框的序列如序列表SEQ ID NO:1所示的序列。Take 1 μL (50ng/uL) of the pEASY-Blunt vector and 4 μL of the target fragment recovered from the gel, mix them in a PCR tube, react in a PCR instrument at 25 degrees for 20 minutes, take 5 μL of the ligation product, and add it to 50 uL of Escherichia coli Trans1-T1 under sterile conditions For the competent cells, use a pipette to gently blow and mix, place in an ice bath for 30 minutes, then heat shock for 90 seconds in a water bath at 42°C, and then immediately cool in an ice bath for 2 minutes, and be careful not to shake. Then add 500 μL of LB culture solution preheated to 37°C to the competent cells, and shake gently at 180 rpm at 37°C for 45 minutes to restore the drug resistance of the bacteria. After recovery of drug resistance, centrifuge at 5000rpm for 3min, discard part of the supernatant in an ultra-clean table, leave 100uL of the supernatant to resuspend the precipitate, take 80uL of the resuspension and spread it evenly on the LB agar plate containing ampicillin (AMP) (100μg/mL), After standing at 37°C for half an hour, invert the plate and continue to incubate at 37°C for 10 hours, until a single white colony can be picked with the naked eye. Pick two colonies and inoculate them in LB culture medium containing 100μg/mL AMP, shake vigorously (180rpm) for 10-12 hours, amplify the target gene with the universal primers on the carrier, and take out the clones that are positive by PCR. Sent to Beijing Aoke Dingsheng Biotechnology Co., Ltd. for sequencing analysis, the results showed that the length of the fragment amplified by gDNA was 1554bp, and the length of the fragment amplified by cDNA was 1371bp, and the target gene amplified by cDNA was analyzed and had a complete open read frame (ORF), the sequence of its open reading frame is as shown in the sequence listing SEQ ID NO: 1.
序列号:SEQ ID NO:1Serial number: SEQ ID NO: 1
序列长度:1371bpSequence length: 1371bp
序列类型:cDNASequence type: cDNA
来源:东方巴贝斯虫Source: Babesia orientalis
序列特征:有正确的开放阅读框(ORF):1371bp;决定位置:起始、终止密码子存在位置:ATG,1位;TGA,1371位。Sequence features: correct open reading frame (ORF): 1371bp; determined positions: start and stop codons exist: ATG, position 1; TGA, position 1371.
6)上述步骤5所得序列ORF全长1371bp,编码蛋白质具有如序列表SEQ ID NO:2所示的氨基酸序列。该蛋白质含有456个氨基酸,分子量为50KD。利用美国国家生物技术信息中心(NCBI,National Center for Biotechnology Information,http://www.ncbi.nlm.nih.gov)网站的BLAST(Basic Local Alignment Search Tool)软件对所测氨基酸序列进行分析。用DNAstar软件包里的Megalign软件,通过ClustalW方法比较的不同物种之间核苷酸序列相似度。结果表明获得了东方巴贝斯虫1-脱氧-D-木桐糖-5-磷酸还原异构酶的全长ORF编码区序列。6) The sequence ORF obtained in step 5 above has a full length of 1371 bp, and the encoded protein has the amino acid sequence shown in SEQ ID NO: 2 in the sequence table. The protein contains 456 amino acids with a molecular weight of 50KD. The determined amino acid sequences were analyzed using BLAST (Basic Local Alignment Search Tool) software on the website of the National Center for Biotechnology Information (NCBI, National Center for Biotechnology Information, http://www.ncbi.nlm.nih.gov). Using the Megalign software in the DNAstar software package, the nucleotide sequence similarity between different species was compared by the ClustalW method. The results showed that the full-length ORF coding region sequence of Babesia orientalis 1-deoxy-D-xyloose-5-phosphate reductoisomerase was obtained.
实施例2:重组原核表达载体的构建及在大肠杆菌中的诱导表达Example 2: Construction of recombinant prokaryotic expression vector and induced expression in Escherichia coli
1)用同源重组的方法设计1-脱氧-D-木桐糖-5-磷酸还原异构酶的表达引物:1) Design primers for the expression of 1-deoxy-D-xautonose-5-phosphate reductoisomerase by means of homologous recombination:
根据1-脱氧-D-木桐糖-5-磷酸还原异构酶基因的ORF序列设计表达引物(BoDXR-F2,BoDXR-R2),上游引物前面加入用于扩增pET32a目的基因的下游引物的反向互补序列作为同源臂,下游引物加入加入用于扩增pET32a目的基因的上游引物的反向互补序列作为同源臂。具体如下:Design expression primers (BoDXR-F2, BoDXR-R2) according to the ORF sequence of the 1-deoxy-D-xautonose-5-phosphate reductoisomerase gene, and add the downstream primers used to amplify the pET32a target gene in front of the upstream primers The reverse complementary sequence is used as a homology arm, and the downstream primer is added to the reverse complementary sequence of the upstream primer used to amplify the pET32a target gene as a homology arm. details as follows:
BoDXR-F2:5’GCCATGGCTGATATC GGATCC ATGGTTGGAAACCACCGC 3’BoDXR-F2: 5'GCCATGGCTGATATC GGATCC ATGGTTGGAAACCACCGC 3'
BoDXR-R2:5’GTGGTGGTGGTGGTG CTCGAG TCACTTTCGACCACTGATGC 3’BoDXR-R2: 5'GTGGTGGTGGTGGTG CTCGAG TCACTTTCGACCACTGATGC 3'
pET32aF:CTCGAGCACCACCACCACCACpET32aF:CTCGAGCACCACCACCACCAC
pET32aR:GGATCC GATATCAGCCATGGCpET32aR:GGATCC GATATCAGCCATGGC
2)重组表达质粒的构建2) Construction of recombinant expression plasmids
用表达引物(BoDXR-F2,BoDXR--R2)对重组质粒pEASY-Blunt-BoDXR进行PCR扩增,获得目的片段,同时用(pET32aF pET32aR)引物扩增表达载体pET32a,PCR反应,跑DNA胶获得目的基因.使用北京全式金DNA琼脂糖凝胶回收试剂盒进行目的片段的回收。分别用分光光度计测回收产物的浓度。结果显示:pET32a的回收浓度为50ng/mL,cDNABoDXR目的基因的回收产物浓度为45ng/mL,根据Vazyme公司one step Cloning Kit说明书,对目的片段与载体片段进行连接。Use expression primers (BoDXR-F2, BoDXR--R2) to carry out PCR amplification on the recombinant plasmid pEASY-Blunt-BoDXR to obtain the target fragment, and at the same time use (pET32aF pET32aR) primers to amplify the expression vector pET32a, perform PCR reaction, and run DNA gel to obtain Target gene. Use Beijing Quanjin DNA Agarose Gel Recovery Kit to recover the target fragment. The concentrations of the recovered products were measured with a spectrophotometer. The results showed that the recovery concentration of pET32a was 50 ng/mL, and the recovery product concentration of cDNABoDXR target gene was 45 ng/mL. According to the instructions of Vazyme's one step Cloning Kit, the target fragment was ligated with the vector fragment.
(1)连接程序(1) Connection program
37℃作用30min37°C for 30min
(2)连接体系(2) Connection system
3)转化3) Conversion
连接结束后,连接产物放置冰上5min,然后取10uL连接产物加入到100uL大肠杆菌DH5a感受态中,用移液器温和吹打混匀,冰浴放置30min。42℃水浴,热激90s,之后立即冰浴2min使之冷却,注意不要晃动。转移菌液至装有500μL预热至37℃的LB培养液中,180rpm 37℃温和振荡45min,使细菌恢复抗药性,取150μL菌液涂布于含有氨苄青霉素(AMP)(100μg/mL)的LB琼脂平板上。倒置平皿于37℃恒温培养箱培养12~16h,挑单个菌落接种于含180μg/mL AMP的LB培养液中,剧烈振摇(230rpm)10~12h后鉴定。同时转化未加入任何外源基因的pET32a空质粒载体作为对照。After the ligation, the ligation product was placed on ice for 5 min, and then 10 uL of the ligation product was added to 100 uL of Escherichia coli DH5a competent, gently blown and mixed with a pipette, and placed in an ice bath for 30 min. Water bath at 42°C, heat shock for 90s, then immediately cool in ice bath for 2min, be careful not to shake. Transfer the bacterial liquid to 500 μL of LB culture medium preheated to 37°C, shake gently at 180 rpm at 37°C for 45 minutes to restore the resistance of the bacteria, take 150 μL of the bacterial liquid and spread it on a medium containing ampicillin (AMP) (100 μg/mL) on LB agar plates. Invert the plate and incubate in a constant temperature incubator at 37°C for 12-16 hours, pick a single colony and inoculate it in LB culture solution containing 180 μg/mL AMP, shake vigorously (230 rpm) for 10-12 hours and then identify. At the same time, the pET32a empty plasmid vector without adding any foreign gene was transformed as a control.
4)阳性克隆子鉴定4) Identification of positive clones
使用载体上游的通用引物和目的基因的下游引物鉴定阳性克隆子是否正确插入。Use the universal primer upstream of the vector and the downstream primer of the target gene to identify whether the positive clone is inserted correctly.
取1ul菌液做PCR,反应体系为25ul,如下:Take 1ul of the bacterial solution for PCR, the reaction system is 25ul, as follows:
PCR反应条件:反应条件为95℃5min;94℃30sec,57℃30sec,72℃1min 40sec;72℃10min;35个循环周期。PCR reaction conditions: the reaction conditions are 95°C for 5min; 94°C for 30sec, 57°C for 30sec, 72°C for 1min and 40sec; 72°C for 10min; 35 cycles.
PCR结束后,跑琼脂糖凝胶电泳,结果显示(如图2),对PCR鉴定为阳性的菌液,复苏摇菌5mL,37度继续摇菌8h,然后按照北京全式金生物有限公司提取质粒的试剂盒说明书的操作来提取质粒,用分光光度计测质粒的浓度,结果为170ng/mL然后用BsaI XhoI(NEB公司)酶再进行双酶切鉴定。After PCR, run agarose gel electrophoresis, the result shows (as shown in Figure 2), for the bacterial solution identified as positive by PCR, resuscitate and shake 5mL of bacteria, continue to shake at 37 degrees for 8h, and then extract according to Beijing Quanshijin Biological Co., Ltd. The plasmid was extracted according to the instruction manual of the plasmid kit, and the concentration of the plasmid was measured with a spectrophotometer, and the result was 170 ng/mL, and then double-enzyme digestion was carried out with BsaI XhoI (NEB Company) enzyme for identification.
酶切体系为:BsaI 1uLEnzyme digestion system: BsaI 1uL
37℃作用1h后跑DNA胶进行鉴定。结果显示酶切除两条预期大小的带,分别是5755bp和1482bp(如图3)。After 1 hour at 37°C, DNA gel was run for identification. The results showed that the enzyme excised two bands of expected size, which were 5755bp and 1482bp respectively (Figure 3).
扩增为阳性的克隆子,取菌液送北京奥科鼎盛生物科技有限公司,进行测序分析,得到1371bp的cDNA序列进行序列比对,说明已成功构建原核重组表达质粒pET32a-BoDXR。The amplified positive clones were taken and sent to Beijing Aoke Dingsheng Biotechnology Co., Ltd. for sequencing analysis. The 1371bp cDNA sequence was obtained for sequence comparison, indicating that the prokaryotic recombinant expression plasmid pET32a-BoDXR has been successfully constructed.
5)pET32a-BoDXR表达载体的构建和小量诱导5) Construction and small-scale induction of pET32a-BoDXR expression vector
将pET32a-BoDXR-DH5a质粒(1μL)无菌条件下转化到大肠杆菌BL21感受态细胞(100μL)中,具体操作方法如上步奏3)。挑取两个pET32a-BoDXR/BL21(DE3)单克隆菌落加入含有AMP的5mL LB培养基中,37℃,180rpm培养至8h左右,然后1:100转接到含有AMP的4mLLB中,继续37℃,180rpm培养3h左右,至OD600为0.5左右,从每个瓶子取2mL置一个新的摇菌瓶不加诱导剂,另2mL加入0.8mmol/L IPTG都继续于37℃诱导3h,然后12000rpm离心2min收集菌体,每管加入40uLddH2O 10uL1M的DTT.50uL2xSDS上样缓冲液,于沸水煮约10min左右,当蛋白由粘稠变为流体状即为完全变性,然后迅速放到冰上冰浴5min,随其跑SDS-PAGE胶鉴定是是否表达,结果显示重组BoDXR在大肠杆菌中成功表达(如图4)。The pET32a-BoDXR-DH5a plasmid (1 μL) was aseptically transformed into Escherichia coli BL21 competent cells (100 μL), and the specific operation method was as above step 3). Pick two pET32a-BoDXR/BL21(DE3) monoclonal colonies and add them to 5mL LB medium containing AMP, culture at 37°C, 180rpm for about 8h, then transfer to 4mLLB containing AMP at 1:100, continue at 37°C , cultured at 180rpm for about 3h, until the OD600 was about 0.5, took 2mL from each bottle and placed it in a new shaker flask without adding inducer, and added 0.8mmol/L IPTG to the other 2mL to continue induction at 37°C for 3h, and then centrifuged at 12000rpm for 2min Collect the bacteria, add 40uLddH 2 O 10uL1M DTT.50uL 2xSDS loading buffer to each tube, cook in boiling water for about 10 minutes, when the protein changes from viscous to fluid, it is completely denatured, and then quickly put it on ice for 5 minutes , followed by running SDS-PAGE gel to identify whether it was expressed, the result showed that the recombinant BoDXR was successfully expressed in Escherichia coli (as shown in Figure 4).
6)重组蛋白的表达产物的可溶性分析6) Solubility analysis of expression products of recombinant proteins
复苏步骤4)成功表达的菌液,按上述方法诱导表达菌液,取1.5mL于8000r/min离心2min收集菌体,用500μL PBS溶液重悬菌体,再次离心集菌,反复洗涤菌体2-3次,以去除培养基残液。Recovery step 4) For the successfully expressed bacterial liquid, induce the expressed bacterial liquid according to the above method, take 1.5 mL and centrifuge at 8000r/min for 2 minutes to collect the bacterial cells, resuspend the bacterial cells with 500 μL of PBS solution, centrifuge again to collect the bacterial cells, and wash the bacterial cells repeatedly 2 -3 times to remove the medium residue.
将每管500μL菌体溶液置于冰水混合物上用超声破碎仪进行破碎,15s/次,间隔30s,每管破碎8-10次,直至液体澄清具有透光性。Place 500 μL of bacterial cell solution in each tube on the ice-water mixture for crushing with an ultrasonic breaker, 15 s/time, with an interval of 30 s, and break each tube 8-10 times until the liquid is clear and translucent.
将已破碎好的样品于4℃条件下12000r/min离心10min。取40μL上清溶液至1.5mLEP管中,加入50μL 2×SDS上样缓冲液,以及10μL DTT溶液,涡旋混匀;将沉淀中加入40μL灭菌ddH2O,50μL 2×SDS上样缓冲液,以及10μL DTT溶液,充分涡旋混匀。将所有样品在沸水中煮10min,之后立即转入冰上静置5min。处理之后的样品经SDS-PAGE电泳检测观察结果。经分析,蛋白在沉淀中表达.如图5A。Centrifuge the crushed sample at 12000r/min for 10min at 4°C. Take 40 μL supernatant solution to a 1.5mLEP tube, add 50 μL 2×SDS sample buffer, and 10 μL DTT solution, vortex and mix well; add 40 μL sterilized ddH 2 O, 50 μL 2×SDS sample buffer , and 10 μL DTT solution, vortexed well. All the samples were boiled in boiling water for 10 min, and immediately transferred to ice for 5 min. The processed samples were detected by SDS-PAGE electrophoresis to observe the results. After analysis, the protein was expressed in the precipitate. As shown in Figure 5A.
7)表达产物的大量纯化和提取7) Mass purification and extraction of expression products
BoDXR重组蛋白的纯化提取:将大量诱导表达的细菌培养物(500mL)用500mL离心管于4℃条件下8000r/min离心10min。细菌沉淀用50mL PBS重悬后,用超声破碎仪破碎至液体澄清;4℃,12000r/min离心10min,弃上清,沉淀用30mLPBS重悬,12000r/min心10min,反复洗涤三次,最后一次向沉淀中加入19.7mL的BufferA,300uL20%SKL(十二烷基肌氨酸钠),100uL1M DTT,振荡器剧烈搅动,使其溶解。室温静置2h,4℃,12000r/min离心20min,上清转移至一个干净的离心管,向上清中加入20%PEG4000210uL,50mM氧化型谷胱甘肽420uL和100mM还原型谷胱甘肽420uL,室温复苏2h,然后把上清放入透析袋中放到PBS中透析2天,透析后得到的蛋白,用蔗糖浓缩。浓缩后跑胶鉴定结果如图5B数字5显示的结果。Purification and extraction of BoDXR recombinant protein: The bacterial culture (500 mL) with a large amount of induced expression was centrifuged in a 500 mL centrifuge tube at 8000 r/min for 10 min at 4°C. After the bacterial pellet was resuspended in 50mL PBS, it was crushed with an ultrasonic breaker until the liquid was clear; 4°C, centrifuged at 12000r/min for 10min, discarded the supernatant, and the pellet was resuspended in 30mL of PBS, centrifuged at 12000r/min for 10min, washed three times repeatedly, and the last time Add 19.7mL of BufferA, 300uL of 20% SKL (sodium lauryl sarcosine), 100uL of 1M DTT to the precipitate, and stir vigorously with a shaker to dissolve it. Let stand at room temperature for 2 hours, centrifuge at 12000r/min for 20min at 4°C, transfer the supernatant to a clean centrifuge tube, add 210uL of 20% PEG4000, 420uL of 50mM oxidized glutathione and 420uL of 100mM reduced glutathione to the supernatant, After recovery at room temperature for 2 hours, the supernatant was put into a dialysis bag and dialyzed in PBS for 2 days. The protein obtained after dialysis was concentrated with sucrose. The results of gel run identification after concentration are as shown in number 5 in Figure 5B.
实施例3:多克隆抗体的制备Embodiment 3: the preparation of polyclonal antibody
(1)BCA法测定蛋白浓度:取5mg/ml蛋白标准品10μL加入到90uLPBS标准稀释液中,稀释至终浓度为0.5mg/ml的标准蛋白;将标准品按0、1、2、4、8、12、16、20μL加到96孔板的标准品孔中,加标准品稀释液补足到20μL;分别把样品用PBS 20倍、10倍5倍,1倍稀释到96孔板的样品孔中至终体积为20μL;各孔加入200μL BCA工作液,37℃放置30min;测定A562。根据标准曲线计算出样品的蛋白浓度。(1) Determination of protein concentration by BCA method: Take 10 μL of 5 mg/ml protein standard product and add it to 90 uLPBS standard diluent, dilute to a final concentration of 0.5 mg/ml standard protein; Add 8, 12, 16, and 20 μL to the standard wells of the 96-well plate, and add the standard diluent to make up to 20 μL; dilute the samples with PBS 20 times, 10 times, 5 times, and 1 times respectively to the sample wells of the 96-well plate The medium to final volume is 20 μL; add 200 μL BCA working solution to each well, and place at 37°C for 30 min; measure A562. Calculate the protein concentration of the sample according to the standard curve.
(2)购买5只健康的SPF级别的昆明小鼠,在初次免疫之前断尾采血作为阴性血清。(2) 5 healthy Kunming mice with SPF level were purchased, and blood was collected by tail docking as negative serum before the first immunization.
(3)制备鼠源的多克隆抗体:初次免疫剂量为每只昆明小鼠注射100ug弗氏完全佐剂乳化的蛋白,接种量为200uL,注射部位在背部和腹部皮下多点注射;再次免疫:初次免疫后14d左右,剂量为200uL/只(重组蛋白含量50ug),加弗氏不完全佐剂。注射部位在背部和腹部皮下多点注射;第三次免疫,在第二次免疫后14d进行,注射剂量和部位同第二次免疫,免疫后7~14d断尾采些许血,用于检测抗体效价,第四次免疫在第三次免疫后7d进行,第四次免疫后7天收集血液,分离血清,保存负20度。(3) Preparation of polyclonal antibody of mouse origin: the initial immunization dose is to inject 100ug of protein emulsified in Freund's complete adjuvant to each Kunming mouse, the inoculation volume is 200uL, and the injection site is injected subcutaneously at multiple points on the back and abdomen; the second immunization: About 14 days after the initial immunization, the dose is 200uL/cattle (recombinant protein content 50ug), plus Freund's incomplete adjuvant. The injection site was subcutaneously injected at multiple points on the back and abdomen; the third immunization was carried out 14 days after the second immunization, the injection dose and site were the same as the second immunization, and some blood was collected from the tail 7-14 days after the immunization for antibody detection Titer, the fourth immunization was carried out 7 days after the third immunization, the blood was collected 7 days after the fourth immunization, the serum was separated, and stored at minus 20 degrees.
实施例4:重组蛋白反应原性的鉴定Example 4: Identification of reactogenicity of recombinant protein
将纯化后的重组蛋白先进行SDS-PAGE电泳,根据目的蛋白带的大小,对照蛋白Marker的相应位置,将电泳完成的SDS-PAGE凝胶切割成所需大小,清水稍作漂洗;按照凝胶的尺寸裁剪6张相同大小的滤纸和1张PVDF膜,将滤纸浸泡于电转缓冲液中5min,将PVDF膜先与甲醇溶液中浸泡15s,用清水漂洗后,浸泡于电转缓冲液中5min;在电转仪负极板上依次放置3张滤纸,SDS-PAGE凝胶,PVDF膜和剩余3张滤纸,完全对齐,在制作电转三明治的每一步都需用玻璃棒轻轻将气泡移除;小心盖上电转仪正极板,计算电转面积,电转仪调至稳流,按1mA/cm2进行电转,电转的时间取决于目的蛋白的分子大小;电转后的PVDF膜用TBST溶液快速漂洗两次,用5%脱脂奶粉室温封闭1-2h或4℃封闭过夜;吸干PVDF膜上的封闭液,用TBST漂洗5次,每次3min,然后将一抗进行适当稀释,室温作用1-2h或4℃过夜孵育;将PVDF膜置于一个新的无菌平皿中,用PBST漂洗5次,每次5min;将二抗适当稀释(一般为1:1000),室温作用1h,用PBST漂洗5次,每次5min;将PVDF膜进行DAB显色或者ECL化学发光显色,观察目的蛋白大小处的显色情况,如图6A/6B/6C/6D。Perform SDS-PAGE electrophoresis on the purified recombinant protein. According to the size of the target protein band and the corresponding position of the control protein marker, cut the electrophoresis-completed SDS-PAGE gel into the required size, and rinse it with water; Cut 6 pieces of filter paper of the same size and 1 piece of PVDF membrane, soak the filter paper in the electrotransfer buffer for 5 minutes, soak the PVDF membrane in methanol solution for 15 seconds, rinse with water, and soak in the electrotransfer buffer for 5 minutes; Place 3 pieces of filter paper, SDS-PAGE gel, PVDF membrane and the remaining 3 pieces of filter paper in sequence on the negative plate of the electrotransfer instrument, and align them completely. In each step of making the electrotransfer sandwich, gently remove the air bubbles with a glass rod; cover carefully The positive plate of the electroporation instrument, calculate the electroporation area, adjust the electroporation instrument to a steady flow, and perform electroporation at 1mA/cm2, the electroporation time depends on the molecular size of the target protein; the PVDF membrane after electroporation is quickly rinsed twice with TBST solution and rinsed with 5% Block with skimmed milk powder at room temperature for 1-2h or overnight at 4°C; blot dry the blocking solution on the PVDF membrane, rinse with TBST 5 times for 3 minutes each time, then properly dilute the primary antibody, act at room temperature for 1-2h or incubate overnight at 4°C ;Put the PVDF membrane in a new sterile plate, rinse 5 times with PBST, 5min each time; properly dilute the secondary antibody (generally 1:1000), act at room temperature for 1h, rinse 5 times with PBST, 5min each time ; Perform DAB color development or ECL chemiluminescence color development on the PVDF membrane, and observe the color development at the size of the target protein, as shown in Figure 6A/6B/6C/6D.
数字1代表的是上的样品是未经IPIG诱导的重组pET32a-BoDXR菌液裂解物;数字2代表的是经IPTG诱导的重组pET32a-BoDXR菌液蛋白提取物;数字3代表的是经处理的东方巴贝斯全虫抗原;数字4代表的是水牛健康红细胞。The number 1 represents that the above sample is the lysate of recombinant pET32a-BoDXR bacterial fluid that has not been induced by IPIG; the number 2 represents the protein extract of recombinant pET32a-BoDXR bacterial liquid induced by IPTG; the number 3 represents the processed Babesia orientalis antigen; the number 4 represents the healthy red blood cells of buffalo.
图6A一抗为鼠源的His-tag,二抗为羊抗鼠IgG多克隆抗体。Figure 6A The primary antibody is a mouse His-tag, and the secondary antibody is a goat anti-mouse IgG polyclonal antibody.
图6B/6C/6D一抗为用重组蛋白pET32a-BoDXR制备的鼠源多克隆抗体,二抗为羊抗鼠IgG多克隆抗体。Figure 6B/6C/6D The primary antibody is a mouse polyclonal antibody prepared with recombinant protein pET32a-BoDXR, and the secondary antibody is a goat anti-mouse IgG polyclonal antibody.
Western blot结果表明,纯化后的重组蛋白BoDXR在68kDa与东方巴贝斯虫全虫抗原有特异性反应,但与健康红细胞无反应(见图6C和6D)。说明体外表达的蛋白于东方巴贝斯虫体内天然表达蛋白一致。The results of Western blot showed that the purified recombinant protein BoDXR had a specific reaction with the Babesia orientalis holoantigen at 68kDa, but had no reaction with healthy red blood cells (see Figure 6C and 6D). It shows that the protein expressed in vitro is consistent with the naturally expressed protein in Babesia orientalis.
<110> 华中农业大学<110> Huazhong Agricultural University
<120> 东方巴贝斯虫1-脱氧-D-木桐糖-5磷酸还原异构酶基因及其编码的蛋白<120> Babesia orientalis 1-deoxy-D-xoutonose-5-phosphate reductoisomerase gene and its encoded protein
<160> 3<160> 3
<210> 1<210> 1
<211> 1371<211> 1371
<212> cDNA<212> cDNA
<213> 东方巴贝斯虫(Babesia orientalis)<213> Babesia orientalis
<400> 1<400> 1
ATGGTTGGAA ACCACCACAG GGGCTCCATT TTATATATGT GGTGTGCAGT GTCGCTGGTG 60ATGGTTGGAA ACCACCACAG GGGCTCCATT TTATATATGT GGTGTGCAGT GTCGCTGGTG 60
GCACTGCCGC AAACCACCGG ATTTCGATAC TCTCCCAATA CTAGTCCATC GTTGAGAAGC 120GCACTGCCGC AAACCACCGG ATTTCGATAC TTCTCCCAATA CTAGTCCATC GTTGAGAAGC 120
AGACCTTTAT TGGCGAATCC TATAAAGGTG GCTGTTATTG GGAGCACTGG AAGCATTGGG 180AGACCTTTTAT TGGCGAATCC TATAAAGGTG GCTGTTATTG GGAGCACTGG AAGCATTGGG 180
ACTCAGACCC TGGATATTAT ACGCCGCATC AATAATACAG CTGATGAACC TAAATTCAAG 240ACTCAGACCC TGGATATTAT ACGCCGCATC AATAATACAG CTGATGAACC TAAATTCAAG 240
GTTGTCGCTT TAACAGCCAA TCGTGACATT TCTGGTTTAG CGAAGCTAGC AGCAGAATTT 300GTTGTCGCTT TAACAGCCAA TCGTGACATT TCTGGTTTAG CGAAGCTAGC AGCAGAATTT 300
ACGCCCCACA TTTTGAATAT TAATTATGGT GGTGAGGAAC TCCGGCAAAC TGTGCCAAAT 360ACGCCCCACA TTTTGAATAT TAATTATGGT GGTGAGGAAC TCCGGCAAAC TGTGCCAAAT 360
AGCTGCGACA TTACCACTGG GAAAGAGGGC GTCTTAAACA TTTGTAAATC CTTCGACTTT 420AGCTGCGACA TTACCACTGG GAAAGAGGGC GTCTTAAACA TTTGTAAATC CTTCGACTTT 420
GACTTGTTGG TAATGGGGAT ATCGGGCTGT GCTGGCATAG AACCAACCAT CGCAGCAGCA 480GACTTGTTGG TAATGGGGAT ATCGGGCTGT GCTGGCATAG AACCAACCAT CGCAGCAGCA 480
CAATCCGGTA AAAGGATGGC GTTAGCTAAC AAAGAATCTG TGGTATCTGC AGGGAGCCTG 540CAATCCGGTA AAAGGATGGC GTTAGCTAAC AAAGAATCTG TGGTATCTGC AGGGAGCCTG 540
TTGCGAAAGG CCATCAACAA AAGTAAATGC GAGCTTATTC CTATTGACTC CGAGCACAAT 600TTGCGAAAGG CCATCAACAA AAGTAAATGC GAGCTTATTC CTATTGACTC CGAGCACAAT 600
GCAATATACC AATGTCTTAC GTCATCTGCA CGTGATTTGT TAGAGCAAAC AAAATTGAGA 660GCAATATACC AATGTCTTAC GTCATCTGCA CGTGATTTGT TAGAGCAAAC AAAATTGAGA 660
GATACGAGGC CCTTGTGTGG TATTTCTAAA AACGTTTTAG ATTCAGTAAA ACGCCTTATC 720GATACGAGGC CCTTGTGTGG TATTTCTAAA AACGTTTTAG ATTCAGTAAA ACGCCTTATC 720
ATCACCAGCA GTGGTGGTCC GTTTAGAGAT ACAAACCCGT CGTTGATGAA GACATTGCGC 780ATCACCAGCA GTGGTGGTCC GTTTAGAGAT ACAAACCCGT CGTTGATGAA GACATTGCGC 780
CTAAAGGATG CTCTTAAGCA TCCTGTTTGG AGTATGGGTG CTAAAATAAC CATTGACTCG 840CTAAAGGATG CTCTTAAGCA TCCTGTTTGG AGTATGGGTG CTAAAATAAC CATTGACTCG 840
TCCACCATGA TGAACAAGGG ATTAGAGGTA ATAGAGGCTC ACGAACTGTT CGGGATCCCA 900TCCACCATGA TGAACAAGGG ATTAGAGGTA ATAGAGGCTC ACGAACTGTT CGGGATCCCA 900
TATGATAGTA TAAAAGTACT CATTCACAAG GAATGTATCG TACATTCAAT GGTGCAATTT 960TATGATAGTA TAAAAGTACT CATTCACAAG GAATGTATCG TACATTCAAT GGTGCAATTT 960
GTTGATAACT CGGTTCTGGC ACAATTATAC AACCCTGATA TGAGGCTCCC AATAGCATAT 1020GTTGATAACT CGGTTCTGGC ACAATTATAC AACCCTGATA TGAGGCTCCC AATAGCATAT 1020
GCACTCAACT GGCCGGACAG GCTTGCTAAT ACCTTACAAG AATTGAACCT CGTTGAACAG 1080GCACTCAACT GGCCGGACAG GCTTGCTAAT ACCTTACAAG AATTGAACCT CGTTGAACAG 1080
ACGCTTACTT TCGCTGATCC TGACTTACAG AAGTTTCCTT GCCTTAAATT GGCTTATGAA 1140ACGCTTACTT TCGCTGATCC TGACTTACAG AAGTTTCCTT GCCTTAAATT GGCTTATGAA 1140
GTTGGGAAGA TGGGAGGACT CTACCCCACA GTTTTAAATG CTGCAAATGA GCAGGCAAAT 1200GTTGGGAAGA TGGGAGGACT CTACCCCACA GTTTTAAATG CTGCAAATGA GCAGGCAAAT 1200
GAACTACTAA GGCGCGATGC AATTGCACAT TGTGAAATAT ACGATCTTGT AAAGCGTGCA 1260GAACTACTAA GGCGCGATGC AATTGCACAT TGTGAAATAT ACGATCTTGT AAAGCGTGCA 1260
ATTGATGCTT TCCAACATCC AAGTATTAGC CAACCTGGCA TTAAGGATAT AATGGAAGCC 1320ATTGATGCTT TCCAACATCC AAGTATTAGC CAACCTGGCA TTAAGGATAT AATGGAAGCC 1320
GATAGCTGGG GAAAGAAACA TGTGATGGAC TGCATCAGTG GTCGAAAGTG A 1371GATAGCTGGG GAAAGAAACA TGTGATGGAC TGCATCAGTG GTCGAAAGTG A 1371
<210> 2<210> 2
<211> 456<211> 456
<212> RNA<212> RNA
<213> 东方巴贝斯虫(Babesia orientalis)<213> Babesia orientalis
<400> 2<400> 2
Met Val Gly Asn His Arg Arg Trp Ser Val Leu Tyr Met Trp Cys 15Met Val Gly Asn His Arg Arg Trp Ser Val Leu Tyr Met Trp Cys 15
Ala Val Ser Leu Val Ala Leu Pro Gln Thr Thr Gly Phe Arg Tyr 30Ala Val Ser Leu Val Ala Leu Pro Gln Thr Thr Gly Phe Arg Tyr 30
Ser Pro Asn Thr Ser Pro Ser Leu Arg Ser Arg Pro Leu Leu Ala 45Ser Pro Asn Thr Ser Pro Ser Leu Arg Ser Arg Pro Leu Leu Ala 45
Asn Pro Ile Lys Val Ala Val Ile Gly Ser Thr Gly Ser Ile Gly 60Asn Pro Ile Lys Val Ala Val Ile Gly Ser Thr Gly Ser Ile Gly 60
Thr Gln Thr Leu Asp Ile Ile Arg Arg Ile Asn Asn Thr Ala Asp 75Thr Gln Thr Leu Asp Ile Ile Arg Arg Ile Asn Asn Thr Ala Asp 75
GAA CCT AAA TTC AAG GTT GTC GCT TTA ACA GCC AAT CGT GAC ATT 270GAA CCT AAA TTC AAG GTT GTC GCT TTA ACA GCC AAT CGT GAC ATT 270
Glu Pro Lys Phe Lys Val Val Ala Leu Thr Ala Asn Arg Asp Ile 90Glu Pro Lys Phe Lys Val Val Ala Leu Thr Ala Asn Arg Asp Ile 90
Ser Gly Leu Ala Lys Leu Ala Ala Glu Phe Thr Pro His Ile Leu 105Ser Gly Leu Ala Lys Leu Ala Ala Glu Phe Thr Pro His Ile Leu 105
Asn Ile Asn Tyr Gly Gly Glu Glu Leu Arg Gln Thr Val Pro Asn 120Asn Ile Asn Tyr Gly Gly Glu Glu Leu Arg Gln Thr Val Pro Asn 120
Ser Cys Asp Ile Thr Thr Gly Lys Glu Gly Val Leu Asn Ile Cys 135Ser Cys Asp Ile Thr Thr Gly Lys Glu Gly Val Leu Asn Ile Cys 135
Lys Ser Phe Asp Phe Asp Leu Leu Val Met Gly Ile Ser Gly Cys 150Lys Ser Phe Asp Phe Asp Leu Leu Val Met Gly Ile Ser Gly Cys 150
Ala Gly Ile Glu Pro Thr Ile Ala Ala Ala Gln Ser Gly Lys Arg 165Ala Gly Ile Glu Pro Thr Ile Ala Ala Ala Gln Ser Gly Lys Arg 165
Met Ala Leu Ala Asn Lys Glu Ser Val Val Ser Ala Gly Ser Leu 180Met Ala Leu Ala Asn Lys Glu Ser Val Val Ser Ala Gly Ser Leu 180
Leu Arg Lys Ala Ile Asn Lys Ser Lys Cys Glu Leu Ile Pro Ile 195Leu Arg Lys Ala Ile Asn Lys Ser Lys Cys Glu Leu Ile Pro Ile 195
Asp Ser Glu His Asn Ala Ile Tyr Gln Cys Leu Thr Ser Ser Ala 210Asp Ser Glu His Asn Ala Ile Tyr Gln Cys Leu Thr Ser Ser Ser Ala 210
Arg Asp Leu Leu Glu Gln Thr Lys Leu Arg Asp Thr Arg Pro Leu 225Arg Asp Leu Leu Glu Gln Thr Lys Leu Arg Asp Thr Arg Pro Leu 225
Cys Gly Ile Ser Lys Asn Val Leu Asp Ser Val Lys Arg Leu Ile 240Cys Gly Ile Ser Lys Asn Val Leu Asp Ser Val Lys Arg Leu Ile 240
Ile Thr Ser Ser Gly Gly Pro Phe Arg Asp Thr Asn Pro Ser Leu 255Ile Thr Ser Ser Gly Gly Pro Phe Arg Asp Thr Asn Pro Ser Leu 255
Met Lys Thr Leu Arg Leu Lys Asp Ala Leu Lys His Pro Val Trp 270Met Lys Thr Leu Arg Leu Lys Asp Ala Leu Lys His Pro Val Trp 270
Ser Met Gly Ala Lys Ile Thr Ile Asp Ser Ser Thr Met Met Asn 285Ser Met Gly Ala Lys Ile Thr Ile Asp Ser Ser Thr Met Met Asn 285
Lys Gly Leu Glu Val Ile Glu Ala His Glu Leu Phe Gly Ile Pro 300Lys Gly Leu Glu Val Ile Glu Ala His Glu Leu Phe Gly Ile Pro 300
Tyr Asp Ser Ile Lys Val Leu Ile His Lys Glu Cys Ile Val His 315Tyr Asp Ser Ile Lys Val Leu Ile His Lys Glu Cys Ile Val His 315
Ser Met Val Gln Phe Val Asp Asn Ser Val Leu Ala Gln Leu Tyr 330Ser Met Val Gln Phe Val Asp Asn Ser Val Leu Ala Gln Leu Tyr 330
Asn Pro Asp Met Arg Leu Pro Ile Ala Tyr Ala Leu Asn Trp Pro 345Asn Pro Asp Met Arg Leu Pro Ile Ala Tyr Ala Leu Asn Trp Pro 345
Asp Arg Leu Ala Asn Thr Leu Gln Glu Leu Asn Leu Val Glu Gln 360Asp Arg Leu Ala Asn Thr Leu Gln Glu Leu Asn Leu Val Glu Gln 360
Thr Leu Thr Phe Ala Asp Pro Asp Leu Gln Lys Phe Pro Cys Leu 375Thr Leu Thr Phe Ala Asp Pro Asp Leu Gln Lys Phe Pro Cys Leu 375
Lys Leu Ala Tyr Glu Val Gly Lys Met Gly Gly Leu Tyr Pro Thr 390Lys Leu Ala Tyr Glu Val Gly Lys Met Gly Gly Leu Tyr Pro Thr 390
Val Leu Asn Ala Ala Asn Glu Gln Ala Asn Glu Leu Leu Arg Arg 405Val Leu Asn Ala Ala Asn Glu Gln Ala Asn Glu Leu Leu Arg Arg 405
Asp Ala Ile Ala His Cys Glu Ile Tyr Asp Leu Val Lys Arg Ala 420Asp Ala Ile Ala His Cys Glu Ile Tyr Asp Leu Val Lys Arg Ala 420
Ile Asp Ala Phe Gln His Pro Ser Ile Ser Gln Pro Gly Ile Lys 435Ile Asp Ala Phe Gln His Pro Ser Ile Ser Gln Pro Gly Ile Lys 435
Asp Ile Met Glu Ala Asp Ser Trp Gly Lys Lys His Val Met Asp 450Asp Ile Met Glu Ala Asp Ser Trp Gly Lys Lys His Val Met Asp 450
Cys Ile Ser Gly Arg Lys 456Cys Ile Ser Gly Arg Lys 456
<210> 3<210> 3
<211> 1554<211> 1554
<212> g DNA<212>g DNA
<213> 东方巴贝斯虫(Babesia orientalis)<213> Babesia orientalis
<400> 3<400> 3
ATGGTTGGAA ACCACCGCAG GTGGTCCGTT TTATATATGT GGTGTGCAGT GTCGCTGGTG 60ATGGTTGGAA ACCACCGCAG GTGGTCCGTT TTATATATGT GGTGTGCAGT GTCGCTGGTG 60
GCGCTGCCGC AAACCACCGG ATTTCGTAAG TTCACAAAAT GGCTGTTTAT AACTCGGCAG 120GCGCTGCCGC AAACCACCGG ATTTCGTAAG TTCACAAAAT GGCTGTTTAT AACTCGGCAG 120
GATACACTCC CAACACTAGT CCATCGTTAA GAAGCCCACC TTTGTAAGTC ATTTTATAGG 180GATACACTCC CAACACTAGT CCATCGTTAA GAAGCCCACC TTTGTAAGTC ATTTTATAGG 180
TTCGACCATT ACATAATCTT CAGATTGGCG AATCCTATAA AGGTGGCTGT TATTGGGAGC 240TTCGACCATT ACATAATCTT CAGATTGGCG AATCCTATAA AGGTGGCTGT TATTGGGAGC 240
ACTGGAAGCA TTGGAACGCA GACCCTGGAT ATTATACGCC GCATCAATAA TACAGCTGGT 300ACTGGAAGCA TTGGAACGCA GACCCTGGAT ATTATACGCC GCATCAATAA TACAGCTGGT 300
GAACCTAAAT TCAAGGTTGT GGCTTTAACA GCCAATCGTG ACATTTCTGG TTTAGCGAAC 360GAACCTAAAT TCAAGGTTGT GGCTTTAACA GCCAATCGTG ACATTTCTGG TTTAGCGAAC 360
CTAGCAGCAG AATTCACGTG AGTTGCATTT GCATAGAACA AAAACACAAT AGGCCCCACA 420CTAGCAGCAG AATTCACGTG AGTTGCATTT GCATAGAACA AAACACAAT AGGCCCCACA 420
TTTTGAATAT TAATTATGGT GCTGAGGAAC TCCGGAAAAC TGTGCCAAAC AATTGCGACA 480TTTTGAATAT TAATTATGGT GCTGAGGAAC TCCGGAAAAC TGTGCCAAAC AATTGCGACA 480
TTACCACGGG GAAGGAGGGT CTCTTAAACA TTTGTAAATC CTTCGACTAT GACTTGTTGG 540TTACCACGGG GAAGGAGGGT CTCTTAAACA TTTGTAAATC CTTCGACTAT GACTTGTTGG 540
TAATGGGGAT ATCGGGATGT GCTGGCATAG AACCAACCAT CGCAGCAGCA CAATCCGGTA 600TAATGGGGAT ATCGGGATGT GCTGGCATAG AACCAACCAT CGCAGCAGCA CAATCCGGTA 600
AAAGGATGGC TTTGGCTAAC AAAGAATCTG TGGTATCTGC AGGTAAATCA GTTGTTTCAT 660AAAGGATGGC TTTGGCTAAC AAAGAATCTG TGGTATCTGC AGGTAAATCA GTTGTTTCAT 660
GTGATCTTAA TTGCCTGTAG GGAGCCTGTT GCGAAAGGCC ATCAACGAAA GTAAATGCGA 720GTGATCTTAA TTGCCTGTAG GGAGCCTGTT GCGAAAGGCC ATCAACGAAA GTAAATGCGA 720
GCTGATTCCT ATTGACTCCG AGCACAATGC AATATACCAA TGTCTTACGT CATCTGCACG 780GCTGATTCCT ATTGACTCCG AGCACAATGC AATATACCAA TGTCTTACGT CATCTGCACG 780
TGATTTGTTA GAGCAAACCA AATTGAGAGA TCCGAGGCCC TTGTGTGGTA TTTCTAAAAA 840TGATTTGTTA GAGCAAACCA AATTGAGAGA TCCGAGGCCC TTGTGTGGTA TTTCTAAAAA 840
CGTTTTAGAT TCAGTAAAAC GCCTTATCAT CACCAGCAGT GGTGGTCCTT TTAGAGATAC 900CGTTTTAGAT TCAGTAAAAC GCCTTATCAT CACCAGCAGT GGTGGTCCTT TTAGAGATAC 900
AAGCCCGTCT TTGATGAATA CAATGCGCCT AAAGGATGCT CTTAAACATC CTGTCTGGAG 960AAGCCCGTCT TTGATGAATA CAATGCGCCT AAAGGATGCT CTTAAACATC CTGTCTGGAG 960
TATGGGTGCT AAAATAACCA TTGACTCCTC CACCATGATG AACAAGGGAT TAGAGGTAAT 1020TATGGGTGCT AAAATAACCA TTGACTCCTC CACCATGATG AACAAGGGAT TAGAGGTAAT 1020
AGAGGCTCAC GAACTGTTTG GGATCCCATA TGATAGTATA AAAGTACTCA TTCACAAGGA 1080AGAGGCTCAC GAACTGTTTG GGATCCCATA TGATAGTATA AAAGTACTCA TTCACAAGGA 1080
ATGTATCGTA CATTCAATGG TGCAATTTGT TGATAACTCG GTTCTGGCAC AATTATACAA 1140ATGTATCGTA CATTCAATGG TGCAATTTGT TGATAACTCG GTTCTGGCAC AATTATACAA 1140
CCCTGATATG AGGCTCCCAA TAGCATATGC ACTCAACTGG CCGGACAGGC TTGCTAATAC 1200CCCTGATATG AGGCTCCCAA TAGCATATGC ACTCAACTGG CCGGACAGGC TTGCTAATAC 1200
CCTGCAAGAA TTGAACCTCG TTGAACAGAC TCTTACTTTC GCTGATCCTG ACTTACAGAA 1260CCTGCAAGAA TTGAACCTCG TTGAACAGAC TCTTACTTTC GCTGATCCTG ACTTACAGAA 1260
GTTCCCCTGC CTTAAATTGG CTTATGAAGT TGGGAAGATG GGAGGACTGT ACCCCACAGT 1320GTTCCCCTGC CTTAAATTGG CTTATGAAGT TGGGAAGATG GGAGGACTGT ACCCCACAGT 1320
TTTAAATGCT GCAAATGAGC AGGCAAATGA ACTACTAAGG CACGATGCAA TTGCACATTG 1380TTTAAATGCT GCAAATGAGC AGGCAAATGA ACTACTAAGG CACGATGCAA TTGCACATTG 1380
TGAAATATAC GATCTTGTAA AGCGTGCCAT TGATGCTTTC CAACATCCAA ATTTAAACCA 1440TGAAATATAC GATCTTGTAA AGCGTGCCAT TGATGCTTTC CAACATCCAA ATTTAAACCA 1440
ACCTGGCATT GAGGTATGCT ATATAATATA CGATTTTATC ATTTGCAGGA TATAATGGAA 1500ACCTGGCATT GAGGTATGCT ATATAATATA CGATTTTATC ATTTGCAGGA TATAATGGAA 1500
GCCGATAGCT GGGGAAAGAA ACATGTGATG GACTGCATCA GTGATCGAAA GTGA 1554GCCGATAGCT GGGGAAAGAA ACATGTGATG GACTGCATCA GTGATCGAAA GTGA 1554
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710086334.9A CN106978425B (en) | 2017-02-17 | 2017-02-17 | 1-deoxy-D-xylulose-5-phosphate reductoisomerase gene and its encoded protein from Babesia orientalis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710086334.9A CN106978425B (en) | 2017-02-17 | 2017-02-17 | 1-deoxy-D-xylulose-5-phosphate reductoisomerase gene and its encoded protein from Babesia orientalis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106978425A true CN106978425A (en) | 2017-07-25 |
CN106978425B CN106978425B (en) | 2019-10-18 |
Family
ID=59338088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710086334.9A Expired - Fee Related CN106978425B (en) | 2017-02-17 | 2017-02-17 | 1-deoxy-D-xylulose-5-phosphate reductoisomerase gene and its encoded protein from Babesia orientalis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106978425B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108314735A (en) * | 2018-01-17 | 2018-07-24 | 华中农业大学 | A kind of monoclonal antibody of anti-vole Babesia and its application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596707A (en) * | 1979-04-30 | 1986-06-24 | University Of Illinois Foundation | Babesia parasite antigen useful in vaccine and diagnostic reagent |
CN1319134A (en) * | 1998-09-22 | 2001-10-24 | 朱马制药有限公司 | Genes of 1-desoxy-D-xylulose biosynthetic pathway |
CN102558332A (en) * | 2012-02-16 | 2012-07-11 | 中国农业科学院上海兽医研究所 | Babesia gibsoni recombinant antigen, diagnostic reagent kit thereof and application of diagnostic reagent kit |
CN105524935A (en) * | 2016-01-07 | 2016-04-27 | 华中农业大学 | Babesia orientilas thrombin gene 1 and protein coded by same |
CN106290854A (en) * | 2015-05-27 | 2017-01-04 | 复旦大学 | Babesiasis Serology test based on micro-fluidic chip and application thereof |
-
2017
- 2017-02-17 CN CN201710086334.9A patent/CN106978425B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596707A (en) * | 1979-04-30 | 1986-06-24 | University Of Illinois Foundation | Babesia parasite antigen useful in vaccine and diagnostic reagent |
CN1319134A (en) * | 1998-09-22 | 2001-10-24 | 朱马制药有限公司 | Genes of 1-desoxy-D-xylulose biosynthetic pathway |
CN102558332A (en) * | 2012-02-16 | 2012-07-11 | 中国农业科学院上海兽医研究所 | Babesia gibsoni recombinant antigen, diagnostic reagent kit thereof and application of diagnostic reagent kit |
CN106290854A (en) * | 2015-05-27 | 2017-01-04 | 复旦大学 | Babesiasis Serology test based on micro-fluidic chip and application thereof |
CN105524935A (en) * | 2016-01-07 | 2016-04-27 | 华中农业大学 | Babesia orientilas thrombin gene 1 and protein coded by same |
Non-Patent Citations (2)
Title |
---|
BRAYTON,K.A.等: "1-deoxy-D-xylulose 5-phosphate reductoisomerase family protein [Babesia bovis T2Bo]", 《GENBANK DATABASE》 * |
SHIV KUMAR等: "Phylogenetic Relationship Among Apicomlexan Parasites Based on In silico Analysis of Enzymes of the MEP Pathway", 《INTERNATIONAL JOURNAL OF BIOINFORMATICS AND BIOMEDICAL ENGINEERING》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108314735A (en) * | 2018-01-17 | 2018-07-24 | 华中农业大学 | A kind of monoclonal antibody of anti-vole Babesia and its application |
CN108314735B (en) * | 2018-01-17 | 2021-05-18 | 华中农业大学 | A kind of monoclonal antibody against Babesia voles and its application |
Also Published As
Publication number | Publication date |
---|---|
CN106978425B (en) | 2019-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111239394A (en) | A kit for rapid detection of novel coronavirus antibodies based on mixed antigens | |
CN105384803B (en) | A kind of Schistosoma japonicum recombinant protein SjSAPLP4 and its encoding gene and application | |
CN101624422B (en) | Recombinant multi-epitope antigen of Schistosoma japonicum and its expression, purification method and application | |
CN108329384B (en) | A kind of Gly m Bd 60K protein antigenic region and screening method based on phage display technology localization | |
CN106146640B (en) | Dust mite allergen and its application | |
CN102690327B (en) | Enterovirus 71 neutralized epitope polypeptide and application thereof | |
CN110642927B (en) | Application of a kind of protein in preparation of medicine for preventing infection of Cryptobacter pyogenes | |
CN104086634A (en) | Brucella omp31 antigenic epitope and monoclonal antibody thereof, and application of brucella omp31 antigenic epitope and monoclonal antibody thereof | |
CN111607000B (en) | Recombinant African swine fever virus p30 subunit soluble fusion protein and preparation method and application thereof | |
CN108822192B (en) | An immunoprotective antigen protein APJL_1976 of Actinobacillus pleuropneumoniae and its application | |
CN102590503B (en) | Indirect blocking ELISA (Enzyme-Linked Immuno Sorbent Assay) detection kit of antibody of porcine torque teno virus type II | |
CN106978425B (en) | 1-deoxy-D-xylulose-5-phosphate reductoisomerase gene and its encoded protein from Babesia orientalis | |
CN113087790B (en) | Anti-African swine fever P72 protein single domain antibody and its application | |
CN107236039A (en) | Recombinate Wzt albumen rabbit anteserum polyclonal antibodies and preparation method thereof | |
CN108794584A (en) | A kind of Actinobacillus pleuropneumoniae immune protective antigen albumin A PJL_1380 and its application | |
CN105254732B (en) | A kind of Schistosoma japonicum recombinant protein SjSAPLP5 and its encoding gene and application | |
CN108715608B (en) | A processing-destructed β-conglycinin β subunit antigenic region based on phage display technology and its screening method | |
CN108727481B (en) | A processing-destructed β-conglycinin α' subunit antigenic region based on phage display technology and its screening method | |
CN108840913B (en) | A kind of Actinobacillus pleuropneumoniae immunoprotective antigen protein APJL_0922 and its application | |
CN103243105B (en) | A kind of Trichina recombinant protein and application | |
CN105524935B (en) | The albumen of Babesia orientalis fibrin ferment plain gene 1 and its coding | |
CN105906716B (en) | Preparation and application of echovirus 9 type VP1 protein specific epitope and fusion protein thereof | |
CN109957575A (en) | A kind of preparation method of goat pox virus p32 soluble protein | |
CN111606979B (en) | A kind of polyclonal antibody of rice streak virus nucleocapsid protein and its preparation method and application | |
CN104086628A (en) | Monoclonal antibody of brucella omp31 protein and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191018 Termination date: 20210217 |